Miriam Nickel

857 total citations
38 papers, 385 citations indexed

About

Miriam Nickel is a scholar working on Physiology, Molecular Biology and Rheumatology. According to data from OpenAlex, Miriam Nickel has authored 38 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Physiology, 13 papers in Molecular Biology and 13 papers in Rheumatology. Recurrent topics in Miriam Nickel's work include Lysosomal Storage Disorders Research (29 papers), Glycogen Storage Diseases and Myoclonus (13 papers) and Calcium signaling and nucleotide metabolism (7 papers). Miriam Nickel is often cited by papers focused on Lysosomal Storage Disorders Research (29 papers), Glycogen Storage Diseases and Myoclonus (13 papers) and Calcium signaling and nucleotide metabolism (7 papers). Miriam Nickel collaborates with scholars based in Germany, United States and Italy. Miriam Nickel's co-authors include Angela Schulz, Alfried Kohlschütter, Peter Slasor, David Jacoby, Susanne Lezius, Temitayo Ajayi, Alessandro Simonati, Kaleb Yohay, Odelya E. Pagovich and Barry E. Kosofsky and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Lancet Neurology and American Journal of Ophthalmology.

In The Last Decade

Miriam Nickel

33 papers receiving 383 citations

Peers

Countries citing papers authored by Miriam Nickel

Since Specialization

Citations

This map shows the geographic impact of Miriam Nickel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miriam Nickel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miriam Nickel more than expected).

Fields of papers citing papers by Miriam Nickel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miriam Nickel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miriam Nickel. The network helps show where Miriam Nickel may publish in the future.

Co-authorship network of co-authors of Miriam Nickel

This figure shows the co-authorship network connecting the top 25 collaborators of Miriam Nickel. A scholar is included among the top collaborators of Miriam Nickel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miriam Nickel. Miriam Nickel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-world clinical outcomes of patients with CLN2 disease treated with cerliponase alfa 2025 ·Frontiers in Neurology ·Angela Schulz, (unknown), (unknown), (unknown), (unknown), Susanne Lezius, Ashok Kumar Jha, (unknown), Peter Slasor, (unknown), Miriam Nickel	1
2	Peripapillary Retinal Nerve Fiber Layer (pRNFL) Thickness – A Novel Biomarker of Neurodegeneration in Late-Infantile CLN2 Disease 2024 ·PubMed ·(unknown), Simon Dulz, (unknown), Miriam Nickel, (unknown), (unknown), Martin S. Spitzer, Angela Schulz, (unknown)	0
3	Language Delay in Patients with CLN2 Disease: Could It Support Earlier Diagnosis? 2023 ·Neuropediatrics ·Miriam Nickel, Paul Gissen, (unknown), Simona Cappelletti, (unknown), Benedetta Ragni, (unknown), Angela Schulz, (unknown), Nicola Specchio	3
4	Safety and efficacy of cerliponase alfa in children with neuronal ceroid lipofuscinosis type 2 (CLN2 disease): an open-label extension study 2023 ·The Lancet Neurology ·Angela Schulz, Nicola Specchio, Emily de los Reyes, Paul Gissen, Miriam Nickel, Marina Trivisano, Shawn C. Aylward, Anupam Chakrapani, (unknown), (unknown), (unknown), Douglas Ballon, Jonathan P. Dyke, Anu Cherukuri, (unknown), Peter Slasor, (unknown)	15
5	Natural history of MRI brain volumes in patients with neuronal ceroid lipofuscinosis 3: a sensitive imaging biomarker 2022 ·Neuroradiology ·(unknown), Angela Schulz, Miriam Nickel, Susanne Lezius, (unknown), Jens Fiehler, Jan Sedlacik, Ulrike Löbel	7
6	Ongoing retinal degeneration despite intraventricular enzyme replacement therapy with cerliponase alfa in late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2 disease) 2022 ·British Journal of Ophthalmology ·Simon Dulz, (unknown), (unknown), (unknown), Frank Schuettauf, Udo Bartsch, (unknown), Miriam Nickel, Martin S. Spitzer, (unknown), Angela Schulz	11
7	Natural History Studies in NCL and Their Expanding Role in Drug Development: Experiences From CLN2 Disease and Relevance for Clinical Trials 2022 ·Frontiers in Neurology ·Miriam Nickel, Angela Schulz	14
8	Management of CLN1 Disease: International Clinical Consensus 2021 ·Pediatric Neurology ·Erika F. Augustine, Heather Adams, Emily de los Reyes, (unknown), (unknown), Norberto Guelbert, Minna Laine, (unknown), Jonathan W. Mink, Miriam Nickel, (unknown), Angela Schulz, Alessandro Simonati, Meral Topçu, Joni A. Turunen, Ruth Williams, Elaine Wirrell, (unknown)	17
9	Investigating health-related quality of life in rare diseases: a case study in utility value determination for patients with CLN2 disease (neuronal ceroid lipofuscinosis type 2) 2021 ·Orphanet Journal of Rare Diseases ·Paul Gissen, Nicola Specchio, Andrew Olaye, Mohit Jain, Thomas Butt, (unknown), (unknown), (unknown), Charlotte Camp, Zlatko Sisic, (unknown), (unknown), Marina Trivisano, Laura Lee, Miriam Nickel, (unknown), Angela Schulz	10
10	First Recognized Patient with Genetic Vitamin E Deficiency Stable after 36 Years of Controlled Supplement Therapy 2020 ·Neurodegenerative Diseases ·Alfried Kohlschütter, Barbara Finckh, Miriam Nickel, Annette Bley, Christoph Hübner	22
11	Validity of a rapid and simple fluorometric tripeptidyl peptidase 1 (TPP1) assay using dried blood specimens to diagnose CLN2 disease 2019 ·Clinica Chimica Acta ·Zoltán Lukács, Miriam Nickel, Simona Murko, (unknown), Angela Schulz, René Santer, Alfried Kohlschütter	16
12	FV 1180. The Unified Batten Disease Rating Scale: An International Collaboration Testing Validation and Reliability in an Independent Cohort of CLN3-Patients 2018 ·Neuropediatrics ·Miriam Nickel, Jonathan W. Mink, (unknown), (unknown), Angela Schulz	0
13	Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study 2018 ·The Lancet Child & Adolescent Health ·Miriam Nickel, Alessandro Simonati, David Jacoby, Susanne Lezius, (unknown), (unknown), Odelya E. Pagovich, Barry E. Kosofsky, Kaleb Yohay, Matthew Downs, Peter Slasor, Temitayo Ajayi, Ronald G. Crystal, Alfried Kohlschütter, Dolan Sondhi, Angela Schulz	89
14	Neurodegenerative Erkrankungen des Kindesalters 2018 ·Medizinische Genetik ·Angela Schulz, Miriam Nickel	0
15	Volumetric Description of Brain Atrophy in Neuronal Ceroid Lipofuscinosis 2: Supratentorial Gray Matter Shows Uniform Disease Progression 2016 ·American Journal of Neuroradiology ·Ulrike Löbel, Jan Sedlacik, Miriam Nickel, Susanne Lezius, Jens Fiehler, Igor Nestrašil, Alfried Kohlschütter, Angela Schulz	19
16	Considering Valproate as a Risk Factor for Rapid Exacerbation of Complex Movement Disorder in Progressed Stages of Late-Infantile CLN2 Disease 2016 ·Neuropediatrics ·Angela Schulz, Jonas Denecke, Jessika Johannsen, Miriam Nickel	6
17	Novel morphological macular findings in juvenile CLN3 disease 2015 ·British Journal of Ophthalmology ·Simon Dulz, Lars Wagenfeld, Miriam Nickel, Guy Richard, Robert A. Schwartz, Udo Bartsch, Alfried Kohlschütter, Angela Schulz	19
18	Demenzerkrankungen bei Kindern und Jugendlichen 2015 ·Alfried Kohlschütter, Angela Schulz, Annette Bley, Miriam Nickel, (unknown)	2
19	Unexplained Loss of Vision in a Child: Consider Bilateral Primary Optic Nerve Sheath Meningioma 2014 ·Neuropediatrics ·Miriam Nickel, Ulrike Löbel, Brigitte Holst, (unknown), Jakob Matschke, Angela Schulz, Alfried Kohlschütter	4
20	Behandlungsergebnisse stationärer psychosomatischer Rehabilitation bei türkischen Migranten: Eine prospektive Studie 2006 ·Das Gesundheitswesen ·Cerstin Nickel, (unknown), Moritz Muehlbacher, (unknown), (unknown), Wiebke Buschmann, Ferdinand Mitterlehner, Claas Lahmann, Christoph Egger, Christian Kettler, Nadine Rother, Karin Tritt, Egon Bachler, Reinhold Fartaćek, Peter Leiberich, Fernando Gil, Wolfhardt K. Rother, Thomas Loew, Miriam Nickel	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact